Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Spain / NCT07408882
Recruiting Not applicable

Evaluation of an Integrated Home Care Model

NCT07408882 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2025-05-15
Last updated
2026-02-18

Condition(s) studied

Older Adults (70 or More) Living at Home With Health and Social Complexity

Investigational drug(s) / intervention(s)

ADMIT integrated care Program

ADMIT integrated care Program: Participants will be attended following an integrated care program which is being co-created by professionals, patients and caregivers, with the following principles: 1. Proactive detection of candidates from both sides (the health and the social services); 2. Designation of a reference and a co-reference professional, one from each side; 3. Shared situational diagnosis based on a comprehensive geriatric assessment; 4. Definition of a shared individual care pathway; 5. Shared follow up. Using a tehcnological platform to facilitate sharing of information and communication between all stakeholders. In some instances, sensoric and robotic devices will be used to monitor and support home care

Study summary

The demographic shift towards a progressive aging of the population represents an unprecedented challenge for Western societies and for the sustainability of health and social systems.

Hypotheses: A complex, multi-component intervention based on integrated home care, facilitated by technological tools and focused on the frail person with complex needs (ADMIT Program):

* Will increase at least 5% of the days spent at home compared to usual care
* Will reduce exacerbations or health or social crisis at home
* Will improve the quality of life and well-being of users and their informal caregiver
* Will improve the experience of the people cared for, their caregivers and professionals in the health and social systems

Main objective: To evaluate the effectiveness of the ADMIT program in increasing the % of days at home of frail elderly people compared to usual practice.

Secondary objectives:

To evaluate the effectiveness of the ADMIT program compared to usual care to reduce exacerbations or situations of crisis that motivate emergency care or hospitalizations.

To evaluate the incremental cost-utility ratio of the ADMIT program in relation to usual practice, exploring different time horizons and different scenarios of population scalability.

To evaluate the experience of the people treated, their informal caregivers and professionals.

To identify the determinants of change and contextual factors of the program implementation process

Methodology:

Hybrid evaluation model that allows evaluating the process, effectiveness, safety and cost-utility while implementing the intervention in real life. Mixed methods, typical of implementation science, will be used, with different stages: First stage: co-creation of the care model and the technological platform with the participation of users and professionals Second stage: evaluation of the process, results and experience through a pragmatic randomized controlled trial with a batched stepped wedge design and comparison with a parallel "external" control group, matched using propensity score techniques.

Applicability and Relevance: The ADMIT program is aligned with the current trend and the shared interest of evolving towards integrated social and health care, keeping people with complex needs in their homes for as long as possible and with the best possible quality of life. The ADMIT project is an implementation project supported by the Catalan Health Department and the Integrated Care Agency. The technological platform that will be co-created and piloted is expected to be adopted by Catalan Health Department for its scaling up in the territory.

Eligibility

Sex
ALL
Min age
70 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Living at home AND * Adjusted Morbidity Group = 3 or 4 or high risk OR Complex or Advanced frailty or chronicity OR Home health care program; AND * Dependent for the basic daily activities OR Social complexity (SSM-CAT positive) OR Dependency grade= 1, 2 or 3 OR Lack of social support OR Home social care program OR Living alone Exclusion Criteria: * Living in a nursing home * Unable to make decisions about care (either by the patient or the caregiver) * Person with needs that exceed the coverage of the program * Not providing informed consent

Primary outcome measure(s)

Trial sites (8)

FacilityCityRegionStatus
CAP Larrard Barcelona Barcelona Recruiting
CAP Sarrià Barcelona Barcelona Recruiting
EBA Vallcarca Barcelona Spain Recruiting
Institut Municipal de Serveis Socials - Ajuntament de Barcelona Barcelona Spain Recruiting
Institut Català de la Salut - Girona Girona Spain Recruiting
Consorci Acció Social La Garrotxa Olot Spain Not Yet Recruiting
Fundació Hospital d'Olot i Comarcal de la Garrotxa Olot Spain Recruiting
Programa de Gestió d'Atenció a la Complexitat (PGAC) Vic Spain Not Yet Recruiting

More Parc Sanitari Pere Virgili trials in Spain

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07408882 on ClinicalTrials.gov ↗ ← All trials in Spain